• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    11/15/23 2:04:31 PM ET
    $AEY
    $ALC
    $ARCT
    $ASTS
    Office Equipment/Supplies/Services
    Industrials
    Ophthalmic Goods
    Health Care
    Get the next $AEY alert in real time by email

    Shares of Shapeways Holdings, Inc. (NASDAQ:SHPW) tumbled during Wednesday’s session following downbeat results.

    Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million.

    Shapeways shares fell 20.8% to $2.36 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares climbed 62.4% to $2.16 after the company reported third-quarter results.
    • Chemomab Therapeutics Ltd. (NASDAQ:CMMB) shares jumped 55% to $0.9497 after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), a fibrotic liver disease.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) climbed 50.8% to $0.8143 after the company reported mixed third-quarter financial results and issued guidance.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) rose 47.7% to $2.32. The company’s board of directors received a letter from Foresite Capital Management and OrbiMed Advisors indicating their intent to explore and evaluate a potential acquisition of the company.
    • SciSparc Ltd. (NASDAQ:SPRC) gained 44.5% to $6.30. SciSparc said 'trial results indicated that SciSparc's proprietary SCI-110 provided a safe and effective solution for alleviating agitation in elderly Alzheimer's patients who participated.'
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) gained 36% to $0.47.
    • Babcock & Wilcox Enterprises, Inc. (NYSE:BW) climbed 34.3% to $1.75.
    • Solid Biosciences Inc. (NASDAQ:SLDB) shares rose 32.7% to $2.83. Solid Biosciences announced IND clearance by the FDA for duchenne muscular dystrophy gene therapy candidate SGT-003.
    • MGO Global, Inc. (NASDAQ:MGOL) shares climbed 32.4% to $0.6566 after reporting a sharp rise in third-quarter sales.
    • Beyond Air, Inc. (NASDAQ:XAIR) gained 28% to $1.7920.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) rose 28% to $4.8262 following third-quarter results.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares climbed 25.2% to $24.34 after the company reported a narrower third-quarter loss.
    • Vicarious Surgical Inc. (NYSE:RBOT) rose 23.7% to $0.2726.
    • CorMedix Inc. (NASDAQ:CRMD) gained 23% to $3.85 as the company posted a narrower-than-expected third-quarter loss.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) climbed 22% to $2.9499 following third-quarter results.
    • Atomera Incorporated (NASDAQ:ATOM) gained 21% to $7.08. Atomera achieved revenue milestone under first commercial license agreement.
    • Gyre Therapeutics, Inc. (NASDAQ:GYRE) climbed 20.5% to $11.45.
    • Dada Nexus Limited (NASDAQ:DADA) climbed 20% to $4.49 following third-quarter results.
    • Icosavax, Inc. (NASDAQ:ICVX) gained 19.1% to $9.63 following strong quarterly earnings.
    • Sangamo Therapeutics, Inc. (NASDAQ:SGMO) jumped 19.1% to $0.4011.
    • Target Corporation (NYSE:TGT) surged 18.2% to $130.89 after the company reported better-than-expected third-quarter financial results. The company will offer more than 10,000 items for holidays, that includes exclusives and many priced under $25.
    • iHeartMedia, Inc. (NASDAQ:IHRT) gained 17.6% to $2.47. iHeartMedia and Global signed a multi-year podcast partnership deal in the UK, Ireland and US.
    • Farfetch Limited (NYSE:FTCH) climbed 17.5% to $1.7750.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) climbed 17% to $0.7605 as the company said that the FDA has granted a Type C meeting to consult on the path forward in developing the tafenoquine regimen of arakoda for hospitalized babesiosis patients.
    • V.F. Corporation (NYSE:VFC) climbed 14.3% to $17.80. JP Morgan upgraded VF from Underweight to Neutral and raised the price target from $15 to $19.
    • Chegg, Inc. (NYSE:CHGG) gained 13.5% to $10.09. The company announced a $150 million buyback.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares gained 11% to $0.1999 after jumping 16% on Tuesday.
    • MYT Netherlands Parent B.V. (NASDAQ:MYTE) rose 11% to $2.2750 after dipping 33% on Tuesday. Mytheresa is expected to release first quarter fiscal year 2024 financial results on Nov. 28, 2023
    • Next.e.GO N.V. (NASDAQ:EGOX) shares climbed 8.1% to $0.5805 after jumping 16% on Tuesday.
    • Tripadvisor, Inc. (NASDAQ:TRIP) gained 6.6% to $18.99. Bernstein upgraded TripAdvisor from Market Perform to Outperform.

    Losers

    • Sadot Group Inc. (NASDAQ:SDOT) shares dipped 31.5% to $0.4903 after posting a wider third-quarter loss.
    • Electriq Power Holdings, Inc. (NASDAQ:ELIQ) shares fell 30.3% to $0.5704 following third-quarter results.
    • Jaguar Global Growth Corporation I (NASDAQ:JGGC) shares fell 27.2% to $5.16.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) fell 25.5% to $0.7001.
    • Global-e Online Ltd. (NASDAQ:GLBE) fell 24.6% to $29.72 as the company reported third-quarter FY23 sales growth of 27% year-over-year, to $133.605 million, missing the consensus of $140.97 million.
    • ADDvantage Technologies Group, Inc. (NASDAQ:AEY) tumbled 23.4% to $0.2450 after posting a loss for the third quarter.
    • Vintage Wine Estates, Inc. (NASDAQ:VWE) fell 23.3% to $0.5822 following quarterly results.
    • Kubient, Inc. (NASDAQ:KBNT) fell 22.8% to $0.1072 after the company announced it decided to voluntarily remove its stock and purchase warrants from the Nasdaq Capital Market due to noncompliance with listing requirements.
    • Aytu BioPharma, Inc. (NASDAQ:AYTU) declined 21.8% to $2.2987 following weak quarterly sales.
    • Troika Media Group, Inc. (NASDAQ:TRKA) dipped 20% to $1.24.
    • Ispire Technology Inc. (NASDAQ:ISPR) declined 18.1% to $13.35 after jumping over 50% on Tuesday. The company reported a narrower loss for its first quarter.
    • Tivic Health Systems, Inc. (NASDAQ:TIVC) shares fell 18.1% to $1.7863 following downbeat sales results for the third quarter.
    • Bitdeer Technologies Group (NASDAQ:BTDR) dipped 15.2% to $4.24.
    • Volcon, Inc. (NASDAQ:VLCN) declined 14.1% to $0.6581.
    • Intrusion Inc. (NASDAQ:INTZ) shares fell 13.7% to $0.4571 as the company reported downbeat third-quarter financial results.
    • Peraso Inc. (NASDAQ:PRSO) fell 9.6% to $0.2079. Peraso recently posted upbeat quarterly results.
    • Marpai, Inc. (NASDAQ:MRAI) dipped 7.7% to $0.59. Marpai recently posted a narrower loss for the third quarter.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) fell 7.1% to $7.25 following quarterly results.
    • Momentus Inc. (NASDAQ:MNTS) fell 6% to $3.3748 after reporting weak quarterly results.
    • Alcon Inc. (NYSE:ALC) fell 5.3% to $71.01 after the company reported weak third-quarter sales and narrowed its full-year forecast.
    • Intapp, Inc. (NASDAQ:INTA) shares declined 4.4% to $38.99. Intapp announced launch of underwritten secondary offering of aggregate of 5 million shares by selling stockholders.

     

    Now Read This: Top 3 Energy Stocks That May Implode In Q4

    Get the next $AEY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEY
    $ALC
    $ARCT
    $ASTS

    CompanyDatePrice TargetRatingAnalyst
    Global-E Online Ltd.
    $GLBE
    3/31/2026$43.00Buy
    BofA Securities
    TripAdvisor Inc.
    $TRIP
    3/27/2026$15.00Neutral → Buy
    BofA Securities
    Solid Biosciences Inc.
    $SLDB
    3/20/2026$26.00Buy
    Guggenheim
    Arcturus Therapeutics Holdings Inc.
    $ARCT
    3/18/2026$22.00Buy
    B. Riley Securities
    Target Corporation
    $TGT
    3/4/2026$116.00Underperform → Mkt Perform
    Bernstein
    Target Corporation
    $TGT
    3/4/2026$110.00 → $145.00Market Perform → Outperform
    Telsey Advisory Group
    Target Corporation
    $TGT
    2/27/2026$103.00Underperform
    BofA Securities
    Alcon Inc.
    $ALC
    2/26/2026$97.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $AEY
    $ALC
    $ARCT
    $ASTS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorMedix to Participate in Needham Virtual Healthcare Conference

    PARSIPPANY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be participating in a fireside chat and investor meetings at the upcoming 25th Annual Needham Virtual Healthcare Conference taking place April 13 – 16, 2026. 25th Annual Needham Virtual Healthcare ConferenceDate:  April 14, 2026Time: 3:00pm EasternFormat: Fireside ChatWebcast:   Link to webcast    About CorMedix CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic produ

    4/7/26 8:30:00 AM ET
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bitdeer Launches SEALMINER A4 Series Bitcoin Mining Rigs, Achieves a Power Efficiency of 9.45 J/TH

    SINGAPORE, April 07, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ:BTDR), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced the launch of its latest self-developed mining machines, the SEALMINER A4 series. This generation integrates Bitdeer's proprietary SEAL04 chips, leveraging advanced process nodes to set competitive benchmarks in performance. The launch marks the successful fulfillment of Bitdeer's previously announced technology roadmap, underscoring its commitment to long-term R&D objectives. The new series includes three models designed for diverse deployment environments: the air-cooling A4 Pro Air, and two hydro-cooling mod

    4/7/26 8:30:00 AM ET
    $BTDR
    Finance: Consumer Services
    Finance

    Solid Biosciences to Participate at Upcoming Investor Conferences

    CHARLESTOWN, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 25th Annual Needham Virtual Healthcare ConferenceBo Cumbo, President and CEO, will participate in a virtual fireside chat on Tuesday, April 14, 2026, at 2:15 pm ET.A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. The webcast replay will be archived for 90 days on the Events page. Piper Sandler Spring Biopharma

    4/7/26 8:00:00 AM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Global-E Online with a new price target

    BofA Securities resumed coverage of Global-E Online with a rating of Buy and set a new price target of $43.00

    3/31/26 8:12:24 AM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    TripAdvisor upgraded by BofA Securities with a new price target

    BofA Securities upgraded TripAdvisor from Neutral to Buy and set a new price target of $15.00

    3/27/26 8:44:32 AM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    Guggenheim initiated coverage on Solid Biosciences with a new price target

    Guggenheim initiated coverage of Solid Biosciences with a rating of Buy and set a new price target of $26.00

    3/20/26 8:37:32 AM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Pittman Robert W bought $48,525 worth of shares (16,349 units at $2.97), increasing direct ownership by 0.26% to 6,231,286 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    3/9/26 8:40:47 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    Chairman and CEO Pittman Robert W bought $105,576 worth of shares (32,468 units at $3.25), increasing direct ownership by 0.53% to 6,214,937 units (SEC Form 4)

    4 - iHeartMedia, Inc. (0001400891) (Issuer)

    3/5/26 5:00:04 PM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    Co-Chief Executive Officer Wang Michael Xue bought $11,959 worth of shares (5,000 units at $2.39), increasing direct ownership by 1% to 466,882 units (SEC Form 4)

    4 - Ispire Technology Inc. (0001948455) (Issuer)

    3/2/26 4:58:37 PM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Collard Craig A

    4 - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Issuer)

    4/6/26 7:06:11 PM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Macrae Sandy

    4 - SANGAMO THERAPEUTICS, INC (0001001233) (Issuer)

    4/3/26 4:15:15 PM ET
    $SGMO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Dubois-Stringfellow Nathalie

    4 - SANGAMO THERAPEUTICS, INC (0001001233) (Issuer)

    4/3/26 4:15:20 PM ET
    $SGMO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Vicarious Surgical Inc.

    SCHEDULE 13D/A - Vicarious Surgical Inc. (0001812173) (Subject)

    4/6/26 7:01:15 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Global-E Online Ltd.

    6-K - Global-E Online Ltd. (0001835963) (Filer)

    4/6/26 4:15:14 PM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    TripAdvisor Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - TripAdvisor, Inc. (0001526520) (Filer)

    4/6/26 4:01:08 PM ET
    $TRIP
    Computer Software: Programming Data Processing
    Technology

    $AEY
    $ALC
    $ARCT
    $ASTS
    Financials

    Live finance-specific insights

    View All

    Alcon Publishes Agenda for 2026 Annual General Meeting

    Alcon welcomes its shareholders to its fourth in-person AGM Alcon Board of Directors proposes to elect R. Scott Herren as a new independent Board member Proposed dividend of CHF 0.28 cash per share Alcon (SIX/NYSE:ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 30, 2026. Alcon is pleased to welcome shareholders to its fourth in-person AGM since becoming an independent, standalone company. The company looks forward to hearing directly from its shareholders at this open format meeting. Alcon's Board of Directors proposes to the AGM to elect R. Scott Herren as a new independent Board member. An accomplished financial executive with thirty-

    4/2/26 4:30:00 PM ET
    $ALC
    Ophthalmic Goods
    Health Care

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results

    Announced in June, positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in study, which U.S. Food and Drug Administration (FDA) reiterated in October may serve as primary basis of approval under Accelerated Approval pathway Rolling submission of Biologics License Agreement (BLA) to FDA seeking ST-920 approval is in progress Transitioned to a clinical-stage neurology company with six clinical sites activated in Phase 1/2 STAND study in chronic neuropathic pain Announced in April, third neurology capsid license agreement, this time with Eli

    3/30/26 4:01:00 PM ET
    $SGMO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEY
    $ALC
    $ARCT
    $ASTS
    Leadership Updates

    Live Leadership Updates

    View All

    Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

    GARDEN CITY, N.Y., March 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities. The Board of Directors has appointed Robert Goodman, the Company's current Chief Commercial Officer and Director, as Chief Executive Officer, effective today. For the past nine years, Mr. Lisi has led Beyond Air, guiding the development and launch of th

    3/26/26 4:05:00 PM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    Tripadvisor and Starboard Value Enter into Cooperation Agreement

    Two Independent Directors Appointed to the Board ImmediatelyTwo Additional Directors to Join the Board at the 2026 Annual MeetingNEEDHAM, Mass., March 23, 2026 /PRNewswire/ -- Tripadvisor, Inc. (NASDAQ:TRIP) today announced that it has entered into a cooperation agreement with Starboard Value LP ("Starboard") under which four new directors will be joining Tripadvisor's Board of Directors (the "Board") to support the Company's value creation efforts. Pursuant to the cooperation agreement, Dhiren Fonseca and Andrew F. Cates have been appointed to the Board, effective immediately. Starboard will recommend two additional directors for election at Tripadvisor's 2026 Annual Meeting of Stockholders

    3/23/26 8:30:00 AM ET
    $PXD
    $TRIP
    $PICO
    Oil & Gas Production
    Energy
    Computer Software: Programming Data Processing
    Technology

    ZIM Updates on Withholding Tax Procedures on March 2026 Cash Dividend

    HAIFA, Israel, March 19, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company"), a global container liner shipping company, hereby updates that in connection with the dividend distribution expected to take place on March 26, 2026, as previously announced by the Company on March 9, 2026 (the "Dividend"), the previously obtained tax ruling from the Israeli Tax Authority ("ITA") on tax withholding procedures relating to the payment of the Dividend to the Company's shareholders (the "Ruling"), as extended, shall apply.   As a result of the Ruling, certain shareholders of the Company ("Shareholders") may be eligible to a reduced Israeli withholding tax rate

    3/19/26 7:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $AEY
    $ALC
    $ARCT
    $ASTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Chemomab Therapeutics Ltd.

    SC 13D/A - Chemomab Therapeutics Ltd. (0001534248) (Subject)

    11/29/24 3:04:59 PM ET
    $CMMB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Chemomab Therapeutics Ltd.

    SC 13G - Chemomab Therapeutics Ltd. (0001534248) (Subject)

    11/21/24 10:59:28 AM ET
    $CMMB
    Biotechnology: Pharmaceutical Preparations
    Health Care